Skip to content

Author

Michaela A. Dinan

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Risk of second primary malignancies in older long-term survivors of breast, prostate, colon, and rectal cancer.

BACKGROUND Cancer survivors face an increased risk of second primary malignancies (SPMs). Understanding SPM incidence and risk factors is crucial for long-term survivorship care. METHODS This was a SEER-Medicare retrospective cohort study of breast, prostate, colon, or rectal cancer survivors diagnosed between 2003-2...

Tendai Kwaramba, Sarah J. Westvold, Jessica B. Long et al. · 0 citations
Open access Oct 2026

Cost implications of broad genomic profiling among Medicare patients with metastatic lung cancer.

37 Background: Broad genomic profiling (BGP) is increasingly used in metastatic non-small cell lung cancer (mNSCLC), but its association with downstream treatment-related Medicare spending compared to focused gene testing (FGT) remains unclear. Methods: We conducted a retrospective cohort study using SEER-Med...

Akintunde O. Aremu, Jessica B. Long, John Rothen et al. · 0 citations
Open access Oct 2026

Biomarker matched biologic use in patients with metastatic colorectal cancer (mCRC).

40 Background: The use of biologic therapy for patients with mCRC is incompletely characterized. We evaluated receipt of biomarker matched guideline concordant treatment with VEGF inhibitors (VEGFi), EGFR antibodies (EGFRa), and immune checkpoint inhibitors (ICI), assessing treatment by sociodemographic, clinic...

T. Salah, Jessica B. Long, John Rothen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.